ACRS 241115 5.00C (ACRS241115C5000) Stock Options, News & Quotes

0.00
0.000.00%

15min DelayClose Nov 5 09:30 ET

0.00High0.00Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Teo knows

Oct 25 14:43

$Aclaris Therapeutics (ACRS.US)$ 4 hours ago when i posted this was 1,35 if you follow you know small profit but cheers and enjoy the weekend

Teo knows

Oct 25 09:47

$Aclaris Therapeutics (ACRS.US)$ nice move watch it

Jaguar8

Sep 17 06:01

NEWS

$Aclaris Therapeutics (ACRS.US)$
Aclaris Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor for the Treatment of Moderate to Severe Atopic Dermatitis
Aclaris Therapeutics (NASDAQ: ACRS) has announced the dosing of the first patient in its Phase 2a clinical trial of ATI-2138, an investigational oral covalent inhibitor of ITK and JAK3, for treating moderate to severe atopic dermatitis. The open-label study aims ...

Stock Region

Jul 19 12:55

Therapeutics Company Announces Royalty Sale For Up To $31.5 Million

Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million.
On July 19, 2024, Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, announced the sale of a portion of its future royalty payments and certain milestones related to OLUMIANT® (baricitinib) to OMERS...

sriz

Jul 16 17:39

$Aclaris Therapeutics (ACRS.US)$ big news